Get startedLog in
    Picture of Emergent BioSolutions logo

    EBS — Emergent BioSolutions News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Emergent BioSolutions Q2 Revenue USD 234.3 Million

    Picture of Emergent BioSolutions logoEmergent BioSolutions
    05/08/2026 21:08
    


BRIEF-Emergent BioSolutions Q2 Revenue USD 234.3 Million



    Aug 05 (Reuters) - Emergent BioSolutions Q2 adjusted EBITDA USD 96.5 million.
    

      

    • Q2 net income USD -180.2 million
      • 

    • Q2 adjusted net income USD 30.9 million
      • 

    • Q2 adjusted EPS USD 0.6
      • 

    • Q2 gross margin 50%
      • 

    • Q2 adjusted gross margin 58%
      •

    Recent news on Emergent BioSolutions

    See all news